PharmaLundensis (PHAL)

PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.

Quotes for PharmaLundensis AB

Right Now

+/-: 0.005
%: 1,82%
Latest: 0.279
High: 0.279
Low: 0.279
Volume: 2 100
Turnover (SEK): 586
Market Value (MSEK): 15,0
Time (Latest trade)

Board

CEO

Staffan Skogvall

Chairperson of the Board

Björn Sivik

Board

Bo Wennergren
Staffan Skogvall
Stefan Ahlfors

Articles of association

News

2025-08-21 17:49:08 Halvårsrapport 2025-01-01 till 2025-06-30
2025-08-21 15:43:25 Halvårsrapport 2025-01-01 till 2025-06-30
2025-08-06 13:09:29 Mindre uppjustering av emissionslikvid
2025-08-04 15:40:55 Flaggning
2025-08-04 13:51:48 Nyemission tecknades för ca 3,13 miljoner kronor

News agencies

2025-08-21 15:51:10 Finwire: Pharmalundensis redovisar som förväntat ingen omsättning, ökad förlust
2025-08-06 13:18:24 Finwire: Pharmalundensis justerar upp emissionslikvid marginellt
2025-08-04 15:55:17 Finwire: Pharmalundensis-chefens ägarandel har minskat genom utspädning
2025-08-04 14:01:14 Finwire: Pharmalundensis nyemission tecknades till 15,6 procent - tillförs 2,93 miljoner kronor
2025-07-11 15:09:24 Finwire: Pharmalundensis förlänger teckningstid i pågående företrädesemission

Analysis

2018-10-29 SvD Börsplus: PharmaLundensis: Aktien kan stiga 4000% (enligt vd)

Largest Owners

Name	Capital %	Votes %	Date
Staffan Skogvall	49,14	49,14	2025-06-26
Vict Th Engwalls Stiftelse	3,33	3,33	2025-06-26
Arne Arvidsson	2,11	2,11	2025-06-26
Arne Skogvall	2,08	2,08	2025-06-26
Avanza Pension	1,19	1,19	2025-06-26
Nordnet Pensionsförsäkring	0,85	0,85	2025-06-26
Tommy Johansson	0,81	0,81	2025-06-26
Staffan Engelbert Bodén	0,66	0,66	2025-06-26
Monica Billgert	0,54	0,54	2025-06-26
Investment Aktiebolaget Balticum	0,49	0,49	2025-06-26

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

PharmaLundensis AB